Wikipedia -WSS

Wikipedia

author：comprehensive 2025-09-30 17:27:33 - browse：4

The federal government will pay hospitals that treat poor and uninsured patients almost $1 billion less next year. Adobe

The federal government will pay hospitals that treat poor and uninsured patients almost $1 billion less next year, a cut that’s more than eight times larger than the one proposed in April.

The Centers for Medicare and Medicaid Services originally said it would cut payments meant to help safety net hospitals by $115 million in 2024. In the final rule released this week, however, that cut grew to $957 million. The pool of money is known as Medicare’s disproportionate share hospital (DSH) payments and uncompensated care payments.

The agency finalized a bigger cut because it lowered its estimated uninsured rate for next year. CMS explained that even though Medicaid enrollment will shrink as states redetermine members’ eligibility, many of those who didn’t lose Medicaid coverage during the pandemic have since gotten or will get insurance from other sources, like employers — and therefore they will remain insured even when they’re kicked off Medicaid.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： WHO recommends dropping component of many flu vaccines

WSS

FDA approves updated Covid vaccines

Private equity could exacerbate cardiology's overuse problem, experts fear

How medical schools plan to diversify without affirmative action

FDA approves updated Covid vaccines

Researchers use wearables data and AI to predict preterm birth risk

New Covid vaccine is recommended for everyone 6 months or older

focus

Wikipedia

Wikipedia

State Dept. review finds Biden bears some blame for Afghanistan failures

Private equity could exacerbate cardiology's overuse problem, experts fear

Trump demands the U.S. pay no more for drugs than other countries … again

Long Covid needs a new name — and a new frame

At least 13 dead in Texas as scorching temps continue

IRA could hurt research into orphan drugs for rare diseases

How one medical school became remarkably diverse

FDA seeks to regulate lab

As demand for Covid shots wanes, Moderna seeks its next success

Medicaid, Medicare dual

explore

What to make of Biden’s latest efforts on cancer research

FDA seeks to regulate lab

After a drawn out lobbying fight, ARPA

Long Covid needs a new name — and a new frame

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

White House touts steps to stem shortages of cancer treatments

knowledge

entertainment

hotspot

focus